米国のサンアントニオ乳がんシンポジウムで発表したDS-1062/Dato-DXdのトリプルネガティブ乳がん患者における第1相臨床試験の最新データについて

Daiichi Sankyo Co. Ltd. published this content on December 08, 2021, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 08:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]